Life Sciences

Article

Algorithm to lab, explore generative AI’s impact in life sciences

Insights to drive value and a competitive advantage

From accelerating clinical development to optimizing quality management, generative artificial intelligence (AI) is beginning to revolutionize the life sciences industry. The next steps businesses take with the technology will be pivotal.

Article

Tech Trends 2023: A life sciences perspective

Discover digital trends that are enhancing the future of life sciences

Our life sciences perspective on Deloitte’s 14th annual Tech Trends report explores six emerging technology trends that have the potential to influence your business’s digital journey over the next 12 months—and beyond.

Article

Digital biomarkers

Navigating the path from ideation to impact through deep phenotyping in precision medicine

Perspectives

Realising the promise of cell and gene therapies in Asia Pacific

Four imperatives for commercial delivery

The next generation of cell and gene therapies (CGTs) holds tremendous potential for therapeutic benefits. To realise this promise, stakeholders need to come together to optimise value chain and recalibrate commercial delivery.

The next generation of cell and gene therapies (CGTs) holds tremendous potential for therapeutic benefits. Based on Deloitte's vast experience in the commercial launch of CGT products, we discuss how stakeholders can come together to optimise value chain and recalibrate commercial delivery.